GAIN THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.13
-5.04%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-34.3%
3 months
-35.4%
6 months
-39.9%
1 year
-35.8%
Year to date
-64.9%
52-week range
$1.13 – $4.18
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$49.3M
P/E
-2.5
P/B
4.4
P/S
—
Revenue
$0
Net income
-$20.11M
Diluted EPS
-0.5
Gross margin
—
Net margin
—
Return on equity
-161.60%
Total debt
$609.87K
Cash
$13.08M
Free cash flow
-$18.95M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$4.68M | — | — | -$4.68M |
| Mar 31, 2026 | $0 | -$5.61M | — | — | -$4.73M |
| Dec 31, 2025 | $0 | -$4.54M | — | — | -$4.62M |
| Sep 30, 2025 | $0 | -$5.28M | — | — | -$4.93M |
| Jun 30, 2025 | $0 | -$5.81M | — | — | -$5.1M |
| Mar 31, 2025 | $0 | -$4.53M | — | — | -$3.82M |
| Dec 31, 2024 | $0 | -$3.77M | — | — | -$3.46M |
| Sep 30, 2024 | $0 | -$4.49M | — | — | -$6.08M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent GANX news
All market newsNo ticker-linked stories are in the current archive.